Literature DB >> 16455945

De novo daptomycin nonsusceptibility in a clinical isolate.

Emil P Lesho, Glenn W Wortmann, David Craft, Kimberly A Moran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16455945      PMCID： PMC1392681          DOI： 10.1128/JCM.44.2.673.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

1.  Resistance studies with daptomycin.

Authors:  J A Silverman; N Oliver; T Andrew; T Li
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.

Authors:  James S Lewis; Aaron Owens; Jose Cadena; Kathryn Sabol; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.

Authors:  L Silvia Munoz-Price; Karen Lolans; John P Quinn
Journal:  Clin Infect Dis       Date:  2005-08-15       Impact factor: 9.079

4.  Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.

Authors:  J Segreti
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

5.  Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.

Authors:  N G Tornieporth; R B Roberts; J John; A Hafner; L W Riley
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

6.  Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  A Mangili; I Bica; D R Snydman; D H Hamer
Journal:  Clin Infect Dis       Date:  2005-02-17       Impact factor: 9.079

Review 7.  Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature.

Authors:  Michael P Stevens; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2005-09-09       Impact factor: 9.079

8.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079
  8 in total
  11 in total

1.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

Review 2.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

3.  Emergence of daptomycin-resistant VRE: experience of a single institution.

Authors:  Mini Kamboj; Nina Cohen; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

Review 4.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

5.  Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.

Authors:  Diana Panesso; Jinnethe Reyes; Elizabeth P Gaston; Morgan Deal; Alejandra Londoño; Masayuki Nigo; Jose M Munita; William R Miller; Yousif Shamoo; Truc T Tran; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

6.  Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.

Authors:  Guiqing Wang; Sitharthan Kamalakaran; Abhay Dhand; Weihua Huang; Caroline Ojaimi; Jian Zhuge; Leslie Lee Yee; Pramod Mayigowda; Pavan Kumar Makam Surendraiah; Nevenka Dimitrova; John T Fallon
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

7.  Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.

Authors:  Truc T Tran; Diana Panesso; Hongyu Gao; Jung H Roh; Jose M Munita; Jinnethe Reyes; Lorena Diaz; Elizabeth A Lobos; Yousif Shamoo; Nagendra N Mishra; Arnold S Bayer; Barbara E Murray; George M Weinstock; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

8.  Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

Authors:  Bhavarth S Shukla; Samuel Shelburne; Katherine Reyes; Mini Kamboj; Jessica D Lewis; Sandra L Rincon; Jinnethe Reyes; Lina P Carvajal; Diana Panesso; Costi D Sifri; Marcus J Zervos; Eric G Pamer; Truc T Tran; Javier Adachi; Jose M Munita; Rodrigo Hasbun; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2016-04-03       Impact factor: 9.079

9.  De novo daptomycin-nonsusceptible enterococcal infections.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 16.126

10.  Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Authors:  Jeremy C Storm; Daniel J Diekema; Jennifer S Kroeger; Sarah J Johnson; Birgir Johannsson
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-29       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.